His primary areas of investigation include Cancer research, Cancer, Carcinogenesis, Pathology and Lung cancer. His biological study spans a wide range of topics, including Transcription factor, Gene, Molecular biology, Tumor suppressor gene and Breast cancer. His Cancer research incorporates themes from Cadherin, DNA methylation, Endometrium, Gene silencing and Epigenetics.
His DNA methylation study incorporates themes from Promoter, Methylation and Transplantation. Edward Gabrielson interconnects Regulation of gene expression, Chromosome and Loss of heterozygosity in the investigation of issues within Carcinogenesis. The study incorporates disciplines such as Immunohistochemistry, Carcinoma and Lung in addition to Lung cancer.
Edward Gabrielson focuses on Cancer research, Pathology, Breast cancer, Lung cancer and Cancer. His Cancer research research is multidisciplinary, incorporating elements of DNA methylation, Carcinogenesis, Tumor suppressor gene, Gene and Cancer cell. His studies deal with areas such as Promoter and Epigenetics as well as DNA methylation.
His work in Gene addresses issues such as Molecular biology, which are connected to fields such as Biochemistry. Edward Gabrielson has included themes like Ductal carcinoma, Lung and Adenocarcinoma in his Pathology study. His Breast cancer research is multidisciplinary, relying on both Biomarker, Methylation and Oncology.
His primary areas of study are Internal medicine, Cancer research, Lung cancer, Oncology and Cancer. His work in the fields of Internal medicine, such as Clinical trial, Immunohistochemistry and Chemotherapy, intersects with other areas such as Carboplatin. His research in Cancer research intersects with topics in Carcinogenesis, Cancer cell, Peripheral, KRAS and T cell repertoire.
The various areas that Edward Gabrielson examines in his Lung cancer study include Major Pathologic Response, Adenocarcinoma, Blockade and Immunotherapy. His Oncology study also includes fields such as
The scientist’s investigation covers issues in Lung cancer, Immune checkpoint, Internal medicine, Oncology and Cancer research. His Neoadjuvant therapy research extends to Lung cancer, which is thematically connected. Many of his research projects under Internal medicine are closely connected to Metformin with Metformin, tying the diverse disciplines of science together.
His study in Oncology is interdisciplinary in nature, drawing from both Bevacizumab, Chemotherapy, Phases of clinical research and Major Pathologic Response. His Cancer research research incorporates elements of Biodistribution, Atezolizumab, Cancer immunotherapy, Durvalumab and Monoclonal antibody. The concepts of his Immunotherapy study are interwoven with issues in Survival rate, Blockade and Gene.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.
Adrian Merlo;James G. Herman;Li Mao;Daniel J. Lee.
Nature Medicine (1995)
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Manel Esteller;Jose Maria Silva;Gemma Dominguez;Felix Bonilla.
Journal of the National Cancer Institute (2000)
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Patrick M. Forde;Jamie E. Chaft;Kellie N. Smith;Valsamo Anagnostou.
The New England Journal of Medicine (2018)
Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.
Steven A. Belinsky;Kristen J. Nikula;William A. Palmisano;Ruth Michels.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
Anju Singh;Vikas Misra;Rajesh K Thimmulappa;Hannah Lee.
PLOS Medicine (2006)
Multiple-laboratory comparison of microarray platforms
Rafael A Irizarry;Daniel Warren;Forrest Spencer;Irene F Kim.
Nature Methods (2005)
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer
Hiromu Suzuki;Edward Gabrielson;Edward Gabrielson;Wei Chen;Wei Chen;Ramaswamy Anbazhagan;Ramaswamy Anbazhagan.
Nature Genetics (2002)
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
P. Cairns;T. J. Polascik;Y. Eby;K. Tokino.
Nature Genetics (1995)
Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program
Kevin J. Cheung;Edward Gabrielson;Zena Werb;Andrew J. Ewald.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: